https://www.selleckchem.com/pr....oducts/hsp990-nvp-hs
Two of 36 patients reached total bone marrow dose of 2 Gy limit. Bone marrow suppression did not develop in these patients. Conclusion The critical organs that seem to affect the treatment scheme in PRRT with 177Lu-DOTATATE are kidney and bone marrow. Although there are established threshold levels, derived from radiotherapy experience, more studies are needed to clarify these dose limits in systemic radionuclide therapies such as PRRT.Recognizing that social factors influence patient health outcomes and utilization, health sy
Like
Comment
Share
